Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ayala is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers.We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers. Our focus is on inhibiting the Notch activating pathway with potentially best in class gamma secretase inhibitors (GSIs...
Ayala is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers.We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers. Our focus is on inhibiting the Notch activating pathway with potentially best in class gamma secretase inhibitors (GSIs).

List your booth number for exhibitions, ask us